Yichang HEC ChangJiang Pharmaceutical Co Ltd Ordinary Shares - Class H 01558
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 9.15
- Day Range
- HKD 9.11–9.32
- 52-Week Range
- HKD 6.02–13.30
- Bid/Ask
- HKD 9.15 / HKD 9.16
- Market Cap
- HKD 8.06 Bil
- Volume/Avg
- 1.0 Mil / 2.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 2.83
- Price/Sales
- 1.16
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic, and cardiovascular diseases. The company's key revenue driver is the anti-viral product division, which manufactures its key product, Its products include Kewei, Ertongshu, Xinhaining, Oumeining and Xining.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 4,618
- Website
- http://www.hec-changjiang.com
Comparables
Valuation
|
Metric
|
01558
|
002038
|
002864
|
|---|---|---|---|
Price/Earnings (Normalized) | 2.83 | 30.04 | 24.32 |
Price/Book Value | 0.92 | 1.34 | 1.85 |
Price/Sales | 1.16 | 8.03 | 2.86 |
Price/Cash Flow | 2.48 | 17.08 | 16.61 |
Price/Earnings
01558
002038
002864
Financial Strength
|
Metric
|
01558
|
002038
|
002864
|
|---|---|---|---|
Quick Ratio | 0.87 | 4.12 | 3.95 |
Current Ratio | 1.40 | 7.67 | 4.16 |
Interest Coverage | 10.10 | — | 26.30 |
Quick Ratio
01558
002038
002864
Profitability
|
Metric
|
01558
|
002038
|
002864
|
|---|---|---|---|
Return on Assets (Normalized) | 18.95% | 3.89% | 5.53% |
Return on Equity (Normalized) | 34.80% | 4.18% | 8.05% |
Return on Invested Capital (Normalized) | 23.93% | 3.93% | 6.48% |
Return on Assets
01558
002038
002864
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Hhckmpnk | Xdytpsy | $80.3 Bil | |||
| Zoetis Inc Class A
ZTS
| Fzlwhwdmws | Thlp | $77.8 Bil | |||
| Haleon PLC ADR
HLN
| Wnznswgk | Snzyf | $37.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Pnrkdlbp | Rhl | $12.1 Bil | |||
| Viatris Inc
VTRS
| Jnwwgst | Tmwl | $12.1 Bil | |||
| Catalent Inc
CTLT
| Tfyktsv | Qvsvfkc | $10.0 Bil | |||
| Perrigo Co PLC
PRGO
| Gpzvjvddp | Dyzj | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Gswfkpz | Cwvrnb | $3.2 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Ymyrmwlbl | Jwym | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Lwmstmlsd | Khgh | $2.7 Bil |